| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 31231 |
|
7,543 |
6,989 |
$633K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,864 |
1,382 |
$452K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,495 |
7,002 |
$335K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,511 |
10,297 |
$321K |
| 86003 |
|
5,011 |
1,315 |
$271K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
657 |
625 |
$200K |
| 31237 |
|
490 |
379 |
$113K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,109 |
1,904 |
$95K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
860 |
799 |
$88K |
| 70486 |
|
834 |
760 |
$76K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,135 |
1,055 |
$75K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
530 |
494 |
$56K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,985 |
1,375 |
$41K |
| 87581 |
|
2,204 |
1,376 |
$39K |
| 30140 |
|
278 |
175 |
$38K |
| 87486 |
|
2,531 |
1,374 |
$32K |
| 95117 |
|
2,784 |
1,560 |
$19K |
| 31575 |
|
350 |
317 |
$19K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
732 |
631 |
$17K |
| 92567 |
|
2,181 |
2,025 |
$17K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
271 |
217 |
$13K |
| 82785 |
|
964 |
740 |
$12K |
| 30117 |
|
65 |
27 |
$9K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
51 |
45 |
$7K |
| 92552 |
|
634 |
609 |
$6K |
| 95115 |
|
1,002 |
536 |
$6K |
| 69210 |
|
319 |
288 |
$5K |
| 92557 |
|
169 |
162 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
457 |
180 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
455 |
293 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
52 |
52 |
$2K |
| 92556 |
|
128 |
125 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
258 |
206 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
167 |
151 |
$1K |
| 99051 |
|
118 |
108 |
$995.64 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
34 |
14 |
$769.95 |
| 95024 |
|
39 |
37 |
$602.22 |
| 92555 |
|
64 |
64 |
$486.38 |
| 92587 |
|
14 |
14 |
$366.43 |
| 36415 |
Collection of venous blood by venipuncture |
581 |
472 |
$300.73 |
| 86318 |
|
19 |
14 |
$154.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
61 |
57 |
$17.71 |
| 87631 |
|
46 |
34 |
$0.00 |